Naphazoline

CHEBI:CHEBI_7470

Chemical Information

Molecular Formula
C14H14N2.HCl
Molecular Mass
246.740
Charge
0
SMILES
Cl.C(C1=NCCN1)c1cccc2ccccc12
InChI
InChI=1S/C14H14N2.ClH/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14;/h1-7H,8-10H2,(H,15,16);1H
InChIKey
DJDFFEBSKJCGHC-UHFFFAOYSA-N

Alternative Names

  • Naphazoline hydrochloride

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:7470
DRON_00010000
7247
oboInOwl#hasDbXref
KEGG:D00743

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:7470
active_ingredient_strength
.27 mg/mL
nui
M0009417
pharm_class_pe
Increased IgG Production [PE]
pharm_class
Glycerol [CS]
pharm_class_cs
Glycerol [CS]
active_ingredient_name
HYPROMELLOSE, UNSPECIFIED
pharm_class_epc
Non-Standardized Chemical Allergen [EPC]
upc
0792554701037
brand_name_suffix
Cool Relief
spl_set_id
e3d60c20-7cbc-4728-8e42-441b64608b88
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
7247
oboInOwl#hasDbXref
KEGG:D00743
oboInOwl#id
CHEBI:7470
generic_name
naphazoline hydrochloride, glycerin
marketing_category
BULK INGREDIENT
dosage_form
SPRAY
product_type
BULK INGREDIENT
brand_name
Nekvnro ORIGINAL NASAL
brand_name_base
Nekvnro ORIGINAL NASAL
product_ndc
84010-023
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
rxcui
2680323
package_marketing_start_date
20110427
unii
6OZP39ZG8H
manufacturer_name
Sato Pharmaceutical, Co., Ltd.
package_description
30 mL in 1 BOTTLE (84010-023-01)
listing_expiration_date
20241231
marketing_start_date
20001102
route
NASAL
application_number
ANDA078208
labeler_name
Sato Pharmaceutical, Co., Ltd.
spl_id
1ff5a255-3e6f-978d-e063-6394a90a785b
package_ndc
84010-023-01
has_treatment
http://purl.obolibrary.org/obo/DOID_6195
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect33954
owl#annotatedSource
t283479
owl#someValuesFrom
t3933409